Alkindi Sprinkle Now Available for Pediatric Adrenocortical Insufficiency By Brian Park, PharmD Publish Date November 24, 2020
FDA Approves Oxlumo for Primary Hyperoxaluria Type 1 By Brian Park, PharmD Publish Date November 24, 2020
Tissue Factor Inhibitor Fast Tracked for COVID-19 By Brian Park, PharmD Publish Date November 24, 2020
Xofluza Approved for Postexposure Prevention of Influenza By Brian Park, PharmD Publish Date November 24, 2020
Loncastuximab Tesirine Gets Priority Review for Relapsed/Refractory Diffuse Large B-Cell Lymphoma By Brian Park, PharmD Publish Date November 24, 2020
Vaccine Candidate AZD1222 Effective Against COVID-19 By Brian Park, PharmD Publish Date November 23, 2020
Antibody Cocktail for COVID-19 Gets Emergency Use Authorization By Diana Ernst, RPh Publish Date November 23, 2020
New Dosing Option Approved for Imfinzi in NSCLC, Bladder Cancer By Brian Park, PharmD Publish Date November 23, 2020
FDA Issues EUA to Baricitinib Plus Remdesivir for Hospitalized COVID-19 Patients By Brian Park, PharmD Publish Date November 20, 2020
Pfizer, BioNTech to Submit EUA Request for COVID-19 Vaccine Candidate By Brian Park, PharmD Publish Date November 20, 2020
Fluvoxamine Evaluated in Patients With Mild COVID-19 By Cassandra Pardini, PharmD Publish Date November 20, 2020
Recall: Lidocaine Identified in Dexmedetomidine Vials By Diana Ernst, RPh Publish Date November 20, 2020
FDA to Review AVT02, a High Concentration Biosimilar to Adalimumab By Brian Park, PharmD Publish Date November 20, 2020
Rilzabrutinib Fast Tracked for Immune Thrombocytopenia By Diana Ernst, RPh Publish Date November 19, 2020
